Is This Tobacco Investment's Risk Worth the Reward?

Lorillard's shareholder returns are impressive and are even greater than those offered by Philip Morris, but the company is facing strict FDA regulation.

Jan 8, 2014 at 4:30PM

The tobacco sector is well known for its impressive shareholder returns, and Lorillard (NYSE:LO) offers some of the best. Indeed, according to my research, through both share buybacks and dividends Lorillard returned 8.9% of its share price to investors during 2012.

The only company that returned more was Reynolds American (NYSE:RAI), which returned 10.1% of its share price. In comparison, Philip Morris returned 8.8% and Altria Group (NYSE:MO) 7.6%. But is the risk of investing in Lorillard worth the reward?

A burning but minty issue
Of course, the risk here is the impending regulation of menthol-cigarette products. I recently covered the key facts of the menthol argument here. However, let's not get caught up in the "will they or won't they" argument, as more than three- quarters of Lorillard's revenue comes from the sale of menthol cigarettes.

That being said, if we think about things logically, it is not unrealistic to suggest that if the U.S. Food and Drug Administration moves against menthol cigarettes, Lorillard will not lose all of its sales overnight. The company is likely to lose some of its sales, but it is more than likely that smokers will switch from menthol to regular cigarettes and stay with Lorillard's Newport brand. In addition, Murray Kessler, the chairman and chief executive of Lorillard, has gone on record to say

"The science does not support differential regulation between menthol cigarettes and non-menthol cigarettes. They're both bad for you. There is not a higher risk of disease...It would be a shame if they went down a path and proposed regulations that weren't based on science and we ended up spending the next 10 years in court. I think it's a very low likelihood."

So it would appear that if the FDA were to move against menthol, Lorillard would fight to the death in court to appeal the decision.

That being said, the company is still likely to report lower sales immediately off the back of any regulation.

It not all bad
Still, Lorillard and its Blu brand have the "first-mover" advantage in the rapidly growing electronic-cigarette market. Blu already has a 40% share of the e-cig market within the U.S., and sales during the second quarter alone totaled $57 million. For the first half of the fiscal year, the gross margin stood at 33% although the net margin was only 8%. However, this did include the cost of rolling out the product across the country; margins should expand into the third quarter and second half of the year.

Not just Lorillard
These menthol threats are not just limited to Lorillard. Altria's Philip Morris USA unit sells menthol versions of Marlboro, and Reynolds makes menthol versions of its Camel brand, as well as Kool and Salem--all menthol-flavored products.

Still, both Reynolds and Altria are less reliant on their menthol sales than Lorillard. Specifically, Altria's menthol Marlboro's only account for around 20% of total sales, and Reynolds' menthol brands only account for 30% of the company's overall sales.

Summing up
All in all, this does push me toward the conclusion that Lorillard is not really worth the risk. Yes, it is unlikely that a menthol ban will come into force, but on the other hand, tobacco stocks are famous for their defensive nature and buy-and-forget qualities. If any regulations were to be introduced, Lorillard would lose this status as investors would have to keep a close eye on the company's progress fighting the regulation.

Meanwhile, Lorillard's peers, Reynolds American and Altria, look safer as their exposure to menthol is more limited. Furthermore, in the case of Altria, investors have more diversification in the form of the company's wine estates and 30% share of SABMiller. Reynolds American also offers a 5% dividend yield at present, more than Lorillard's current offering of 4.3%.

So overall, Lorillard is not worth the risk. 

Tobacco stocks aren't the only great dividend picks out there
One of the dirty secrets that few finance professionals will openly admit is the fact that dividend stocks as a group handily outperform their non-dividend paying brethren. The reasons for this are too numerous to list here, but you can rest assured that it’s true. However, knowing this is only half the battle. The other half is identifying which dividend stocks in particular are the best. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor’s portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.


Fool contributor Rupert Hargreaves owns shares of Altria Group. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers